Appl Clin Inform 2023; 14(01): 134-143
DOI: 10.1055/a-2004-6669
Review Article

Electronic Medical Record–Based Electronic Messaging Among Patients with Breast Cancer: A Systematic Review

Meghan Conroy
1   Medical College of Wisconsin, Milwaukee, Wisconsin, United States
,
Miracle Powell
1   Medical College of Wisconsin, Milwaukee, Wisconsin, United States
,
Elizabeth Suelzer
1   Medical College of Wisconsin, Milwaukee, Wisconsin, United States
,
Saagar Pamulapati
2   Mercyhealth, Loves Park, Illinois, United States
,
Heun Min
1   Medical College of Wisconsin, Milwaukee, Wisconsin, United States
,
Tamiah Wright
3   Froedtert Hospital, Milwaukee, Wisconsin, United States
,
Sailaja Kamaraju
1   Medical College of Wisconsin, Milwaukee, Wisconsin, United States
› Author Affiliations
Preview

Abstract

Background Electronic medical record (EMR) systems and electronic messages are an increasingly common conduit between physicians and patients. Clear benefits of this type of communication have been established, especially among cancer patients. Studies suggest that patient portals and electronic messaging platforms can help with care coordination between oncology providers and facilitate asynchronous patient-provider communication. Despite the many benefits, there is little research regarding EMR and secure messaging use, particularly among patients with breast cancer.

Objectives The objective of this systematic review was to examine the evidence supporting the use of EMR-based messaging systems in patients with breast cancer.

Methods A systematic literature search of Ovid MEDLINE, PubMed, Scopus, Web of Science CINAHL, and Cochrane Library was conducted. Studies were required to be published between 2005 and 2022 and report data on demographic information and electronic messaging between patients and providers. Studies were excluded if they reported insufficient data, did not include breast cancer patients, or were not published in English.

Results This study identified 10 articles that met inclusion criteria. The resulting studies investigated topics such as: patterns of messaging and medication adherence, cancer screening, messaging as a predictor of behavior or outcomes, and symptom management. The literature indicates that electronic messaging with providers was associated with clinical benefits for breast cancer patients and improved screening behaviors.

Conclusion This review uncovered multiple areas to focus future research on, including ideal volume of electronic messages sent and their relation to prescription adherence, studies focusing solely on the breast cancer population, racial disparities in electronic messaging, and provider perceptions of electronic messaging. It is vital that more work be done to understand barriers and gaps in EMR usage to ensure that all individuals can access this increasingly essential medical service while minimizing physician workload and burnout.

Protection of Human and Animal Subjects

No human subjects were involved in this research.


Supplementary Material



Publication History

Received: 09 October 2022

Accepted: 27 December 2022

Accepted Manuscript online:
29 December 2022

Article published online:
15 February 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany